Commercially marketed CBD-infused products are not subject to explicit federal regulations. As a result, third-party lab testing has frequently revealed inconsistencies between the percentage of CBD advertised and the amount actually contained in some of these products.
By Kellen Russoniello, student, George Washington University Law Center and NORML legal intern [Update: A…
We get many comments on our stories about K2/Spice, the chemical “JWH-018” and others like…
The United States Drug Enforcement Administration (DEA) today, as anticipated, exercised its ‘emergency scheduling authority’…
Well, if nothing else, the United States Drug Enforcement Administration is predictable. DEA says it…